Actithera Raises $75.5 Million to Advance Precision Radioligand Therapy
July 9, 2025
Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor Capital